These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [A study on a hot-water extract from delipidated BCG (author's transl)]. Sato H; Sato K; Ito M; Kumano N; Motomiya M; Konno K; Yokosawa A Kekkaku; 1981 Jan; 56(1):11-6. PubMed ID: 7014973 [No Abstract] [Full Text] [Related]
6. [Adjuvant immunotherapy with BCG for malignant brain tumors (author's transl)]. Miki Y; Sano K; Takakura K; Mizutani H Neurol Med Chir (Tokyo); 1976 Jul; 16(4 pt 2):357-64. PubMed ID: 62316 [No Abstract] [Full Text] [Related]
7. Activated macrophages and the antitumor action of BCG. Alexander P Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313 [No Abstract] [Full Text] [Related]
9. [Dynamic aspects of immunocompetent cells for delayed hypersensitivity. Relationship between macrophage migration inhibition phenomenon and delayed skin reaction (author's transl)]. Kino T Kekkaku; 1974 May; 49(5):117-25. PubMed ID: 4605633 [No Abstract] [Full Text] [Related]
10. [Defense mechanisms against tuberculosis infection in the immune host. The interrelation between activated macrophages and 14C-labeled BCG in primary BCG lesions and those of reinfection (author's transl)]. Ando M; Shima K; Tokuomi H Kekkaku; 1975 Jun; 50(6):153-60. PubMed ID: 1102749 [No Abstract] [Full Text] [Related]
11. [Antimycobacterial mechanisms of activated alveolar macrophages (author's transl)]. Ando M; Sugimoto M; Suga M; Horio S Kekkaku; 1980 Nov; 55(11):497-9. PubMed ID: 7007701 [No Abstract] [Full Text] [Related]
12. Immunotherapy of guinea pig cancer with BCG. Zbar B Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693 [No Abstract] [Full Text] [Related]
13. [Induction of suppressor adherent cells by injecting heavy dose of live BCG. II. The characterization of suppressor adherent cells (author's transl)]. Kato K Kekkaku; 1980 Oct; 55(10):443-6. PubMed ID: 6453248 [No Abstract] [Full Text] [Related]
14. Comparison of chemical and biological properties of water-soluble adjuvants prepared from Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium smegmatis. Kumazawa Y; Shibusawa A; Nakagawa N; Kojima Y; Mizunoe K Kitasato Arch Exp Med; 1976 Dec; 49(4):153-62. PubMed ID: 829910 [No Abstract] [Full Text] [Related]
15. The discovery of immunostimulatory DNA sequence. Yamamoto S; Yamamoto T; Tokunaga T Springer Semin Immunopathol; 2000; 22(1-2):11-9. PubMed ID: 10944796 [No Abstract] [Full Text] [Related]
17. [The influence of Mycobacterium bovis BCG-Prague, respectively of Mycobacterium smegmatis on the growth of the intratracheally transplanted Deal's sarcoma in guinea pigs (author's transl)]. Schwartz E; Vincúrová M; Badalík L Bratisl Lek Listy; 1975 Sep; 64(3):272-84. PubMed ID: 1100201 [No Abstract] [Full Text] [Related]
18. Depression of protective mechanisms against microörganisms in tumor-bearing mice and its restoration by adjuvants. Matsuo K; Nomoto K; Shimotori S; Takeya K Gan; 1977 Aug; 68(4):465-71. PubMed ID: 99344 [TBL] [Abstract][Full Text] [Related]
19. [The influence of Mycobacterium bovis BCG-prague, respectively of Mycobacterium smegmatis on the growth of the intratracheally transplanted Deal's sarcoma in guinea pigs (author's transl)]. Schwartz E; Vincúrová M; Badalik L Bratisl Lek Listy; 1975 Sep; 64(3):272-84. PubMed ID: 1098744 [No Abstract] [Full Text] [Related]